Skip to main content
OpenTrials

Clinical trial condition

Recurrent Fallopian Tube Cancer

Explore clinical trials studying Recurrent Fallopian Tube Cancer. Study availability and eligibility vary by location and protocol.

13 public trials 2 recruiting studies
Refine in advanced search Browse all conditions

Recurrent Fallopian Tube Cancer trial results

Recruiting

Study of REGN4018 (Ubamatamab) Administered Alone or in Combination With Cemiplimab in Adult Patients With Recurrent Ovarian Cancer or Other Recurrent Mucin-16 Expressing (MUC16+) Cancers

NCT03564340

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +23 more
Locations
  • University of Alabama_6th Ave Birmingham, Alabama, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Dana Farber / Harvard Cancer Center Boston, Massachusetts, United States
  • Mayo Clinic - Rochester Rochester, Minnesota, United States
View all 52 locations
View Trial Details
Completed

Metformin and Chemotherapy in Treating Patients With Stage III-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

NCT02122185

Conditions
Adnexal Diseases, Brenner Tumor, Carcinoma, +57 more
Locations
  • University of Alabama Birmingham, Alabama, United States
  • Mitchell Cancer Institute - University of South Alabama Mobile, Alabama, United States
  • City of Hope Duarte, California, United States
  • NCH Medical Group- Northwest Community Hospital Arlington Heights, Illinois, United States
View Trial Details
Completed

Cediranib Maleate in Treating Patients With Persistent, Recurrent, or Refractory Advanced Ovarian Epithelial, Peritoneal Cavity, or Fallopian Tube Cancer

NCT00278343

Conditions
Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +21 more
Locations
  • City of Hope Duarte, California, United States
  • University of Southern California/Norris Cancer Center Los Angeles, California, United States
  • City of Hope Medical Group Inc Pasadena, California, United States
  • University of California at Davis Cancer Center Sacramento, California, United States
View all 28 locations
View Trial Details

Related conditions